NASDAQ Health Care Index (IXHC) Companies by Market Cap
The NASDAQ Health Care Index (IXHC) tracks 976 constituent companies with a combined market cap of $2.51 Trillion, covering the largest publicly traded companies in USA. This ranking lists all IXHC index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$2.51 Trillion
Constituent Companies
976
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 251 |
Iovance Biotherapeutics Inc
NASDAQ:IOVA |
% | $1.03 Billion | Healthcare | Biotechnology | $4.04 | -4.49% |
| 252 |
Eton Pharmaceuticals Inc
NASDAQ:ETON |
% | $1.02 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $37.34 | +1.99% |
| 253 |
Absci Corp
NASDAQ:ABSI |
% | $1.01 Billion | Healthcare | Biotechnology | $10.21 | -3.68% |
| 254 |
Sana Biotechnology Inc
NASDAQ:SANA |
% | $1.01 Billion | Healthcare | Biotechnology | $3.64 | -5.45% |
| 255 |
Nutex Health Inc
NASDAQ:NUTX |
% | $1.01 Billion | Healthcare | Medical Care Facilities | $179.15 | -2.59% |
| 256 |
Ventyx Biosciences Inc
NASDAQ:VTYX |
% | $1.00 Billion | Healthcare | Biotechnology | $14.00 | +0.00% |
| 257 |
Pacira BioSciences, Inc.
NASDAQ:PCRX |
% | $1.00 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $25.54 | +0.24% |
| 258 |
Verve Therapeutics Inc
NASDAQ:VERV |
% | $994.04 Million | Healthcare | Biotechnology | $11.13 | +0.00% |
| 259 |
Vor Biopharma Inc
NASDAQ:VOR |
% | $976.97 Million | Healthcare | Biotechnology | $18.03 | -5.80% |
| 260 |
Sellas Life Sciences Group Inc
NASDAQ:SLS |
% | $968.80 Million | Healthcare | Biotechnology | $12.62 | -1.10% |
| 261 |
Kura Oncology Inc
NASDAQ:KURA |
% | $968.53 Million | Healthcare | Biotechnology | $10.91 | -4.72% |
| 262 |
InMode Ltd
NASDAQ:INMD |
% | $957.62 Million | Healthcare | Medical Devices | $15.15 | -0.85% |
| 263 |
Solid Biosciences LLC
NASDAQ:SLDB |
% | $956.93 Million | Healthcare | Biotechnology | $9.72 | -6.72% |
| 264 |
Fortrea Holdings Inc.
NASDAQ:FTRE |
% | $948.95 Million | Healthcare | Biotechnology | $17.86 | +0.56% |
| 265 |
DBV Technologies
NASDAQ:DBVT |
% | $945.74 Million | Healthcare | Biotechnology | $15.98 | -3.09% |
| 266 |
Maravai Lifesciences Holdings Inc
NASDAQ:MRVI |
% | $922.34 Million | Healthcare | Biotechnology | $6.36 | +4.43% |
| 267 |
Pharming Group NV
NASDAQ:PHAR |
% | $916.72 Million | Healthcare | Biotechnology | $13.77 | -0.65% |
| 268 |
Anteris Technologies Global Corp. Common Stock
NASDAQ:AVR |
% | $911.12 Million | Healthcare | Medical Instruments & Supplies | $9.36 | -4.20% |
| 269 |
Geron Corporation
NASDAQ:GERN |
% | $910.96 Million | Healthcare | Biotechnology | $1.42 | -5.33% |
| 270 |
MeiraGTx Holdings PLC
NASDAQ:MGTX |
% | $909.07 Million | Healthcare | Biotechnology | $12.34 | -7.84% |
| 271 |
Olema Pharmaceuticals Inc
NASDAQ:OLMA |
% | $900.55 Million | Healthcare | Biotechnology | $11.85 | -0.50% |
| 272 |
Cullinan Oncology LLC
NASDAQ:CGEM |
% | $894.21 Million | Healthcare | Biotechnology | $17.87 | -1.43% |
| 273 |
Janux Therapeutics Inc
NASDAQ:JANX |
% | $878.78 Million | Healthcare | Biotechnology | $16.14 | -1.59% |
| 274 |
Annexon Inc
NASDAQ:ANNX |
% | $866.73 Million | Healthcare | Biotechnology | $5.63 | -2.93% |
| 275 |
Opko Health Inc
NASDAQ:OPK |
% | $860.81 Million | Healthcare | Diagnostics & Research | $1.23 | -8.89% |
| 276 |
BioAge Labs, Inc
NASDAQ:BIOA |
% | $856.34 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $21.79 | -10.50% |
| 277 |
Theravance Biopharma Inc
NASDAQ:TBPH |
% | $854.78 Million | Healthcare | Biotechnology | $16.90 | -0.18% |
| 278 |
Phathom Pharmaceuticals Inc
NASDAQ:PHAT |
% | $851.52 Million | Healthcare | Biotechnology | $10.92 | -13.44% |
| 279 |
Amphastar P
NASDAQ:AMPH |
% | $850.55 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $19.29 | +3.04% |
| 280 |
Lexicon Pharmaceuticals Inc
NASDAQ:LXRX |
% | $839.53 Million | Healthcare | Biotechnology | $2.17 | -2.25% |
| 281 |
Arbutus Biopharma Corp
NASDAQ:ABUS |
% | $831.63 Million | Healthcare | Biotechnology | $4.67 | -2.81% |
| 282 |
Oric Pharmaceuticals Inc
NASDAQ:ORIC |
% | $828.14 Million | Healthcare | Biotechnology | $10.46 | -3.59% |
| 283 |
Xencor Inc
NASDAQ:XNCR |
% | $827.65 Million | Healthcare | Biotechnology | $14.96 | -5.62% |
| 284 |
Kalvista Pharmaceuticals Inc
NASDAQ:KALV |
% | $820.37 Million | Healthcare | Biotechnology | $27.00 | +0.00% |
| 285 |
CytomX Therapeutics Inc
NASDAQ:CTMX |
% | $805.50 Million | Healthcare | Biotechnology | $3.70 | -1.60% |
| 286 |
ARS Pharmaceuticals, Inc
NASDAQ:SPRY |
% | $768.59 Million | Healthcare | Biotechnology | $7.74 | -2.52% |
| 287 |
Replimune Group Inc
NASDAQ:REPL |
% | $762.97 Million | Healthcare | Biotechnology | $9.94 | -9.60% |
| 288 |
Neurogene Inc
NASDAQ:NGNE |
% | $762.90 Million | Healthcare | Biotechnology | $38.32 | -3.31% |
| 289 |
Oculis Holding AG Ordinary shares
NASDAQ:OCS |
% | $762.50 Million | Healthcare | Biotechnology | $13.15 | -3.52% |
| 290 |
CeriBell, Inc
NASDAQ:CBLL |
% | $740.64 Million | Healthcare | Medical Devices | $19.52 | -0.20% |
| 291 |
Esperion Therapeutics Inc
NASDAQ:ESPR |
% | $726.75 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $3.18 | +0.00% |
| 292 |
Beta Bionics, Inc. Common Stock
NASDAQ:BBNX |
% | $721.01 Million | Healthcare | Medical Devices | $16.95 | -0.47% |
| 293 |
Astria Therapeutics Inc
NASDAQ:ATXS |
% | $718.13 Million | Healthcare | Biotechnology | $5873.65 | +10.87% |
| 294 |
Omeros Corporation
NASDAQ:OMER |
% | $712.90 Million | Healthcare | Biotechnology | $10.01 | -2.63% |
| 295 |
XOMA Royalty Corporation
NASDAQ:XOMA |
% | $710.16 Million | Healthcare | Biotechnology | $40.17 | -9.16% |
| 296 |
Castle Biosciences Inc
NASDAQ:CSTL |
% | $696.98 Million | Healthcare | Diagnostics & Research | $22.98 | -3.12% |
| 297 |
Phibro Animal Health Corporation
NASDAQ:PAHC |
% | $695.27 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $33.00 | +2.90% |
| 298 |
Ironwood Pharmaceuticals Inc
NASDAQ:IRWD |
% | $686.44 Million | Healthcare | Drug Manufacturers - Specialty & Generic | $4.21 | -5.82% |
| 299 |
Aura Biosciences Inc
NASDAQ:AURA |
% | $683.95 Million | Healthcare | Biotechnology | $7.00 | +2.34% |
| 300 |
Regenxbio Inc
NASDAQ:RGNX |
% | $659.14 Million | Healthcare | Biotechnology | $12.75 | -8.60% |
Complete list of all companies in the IXHC index ranked by market capitalization. Track index constituent performance and market values. View all indices